Ksv Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.09 M
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -60.86%
- Profit Growth -66.95%
- Ebitda -199.80%
- Net Worth 0.50%
- Total Assets 32.60%
About Ksv Pharmaceutical
Ksv Pharmaceutical Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2008 and has a history of 17 years and one month. Its registered office is in Bilaspur, Chattisgarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.09 M, as per Ministry of Corporate Affairs (MCA) records.
Suraj Jajodia and Prakash Jajodia serve as directors at the Company.
Company Details
-
Location
Bilaspur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230CT2008PTC020499
-
Company No.
020499
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jan 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
What products or services does Ksv Pharmaceutical Private Limited offer?
Ksv Pharmaceutical Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Psychotherapeutic Agents, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Skin Lightening Drugs.
Who are the key members and board of directors at Ksv Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Jajodia
|
Director | 01-Jan-2008 | Current |
|
Prakash Jajodia
|
Director | 01-Jan-2008 | Current |
Financial Performance of Ksv Pharmaceutical.
Ksv Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 60.86% decrease. The company also saw a substantial fall in profitability, with a 66.95% decrease in profit. The company's net worth moved up by a moderate rise of 0.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ksv Pharmaceutical?
In 2023, Ksv Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ksv Pharmaceutical?
Unlock and access historical data on people associated with Ksv Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ksv Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ksv Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.